114 related articles for article (PubMed ID: 38142011)
21. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; FĂĽhrer-Sakel D; Piontek J; Krause G
Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
[TBL] [Abstract][Full Text] [Related]
22. Claudin-1 correlates with poor prognosis in lung adenocarcinoma.
Sun BS; Yao YQ; Pei BX; Zhang ZF; Wang CL
Thorac Cancer; 2016 Sep; 7(5):556-563. PubMed ID: 27766775
[TBL] [Abstract][Full Text] [Related]
23. Plasma-activated medium ameliorates the chemoresistance of human lung adenocarcinoma cells mediated via downregulation of claudin-2 expression.
Eguchi H; Yu Y; Yoshino Y; Hara H; Tanaka H; Ikari A
Arch Biochem Biophys; 2024 Jan; 751():109846. PubMed ID: 38056686
[TBL] [Abstract][Full Text] [Related]
24. RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.
Singh A; Boldin-Adamsky S; Thimmulappa RK; Rath SK; Ashush H; Coulter J; Blackford A; Goodman SN; Bunz F; Watson WH; Gabrielson E; Feinstein E; Biswal S
Cancer Res; 2008 Oct; 68(19):7975-84. PubMed ID: 18829555
[TBL] [Abstract][Full Text] [Related]
25. MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis.
Tian H; Zhang D; Gao Z; Li H; Zhang B; Zhang Q; Li L; Cheng Q; Pei D; Zheng J
Cancer Gene Ther; 2014 Oct; 21(10):416-26. PubMed ID: 25236495
[TBL] [Abstract][Full Text] [Related]
26. Down-Regulation of Claudin-2 Expression by Cyanidin-3-Glucoside Enhances Sensitivity to Anticancer Drugs in the Spheroid of Human Lung Adenocarcinoma A549 Cells.
Eguchi H; Matsunaga H; Onuma S; Yoshino Y; Matsunaga T; Ikari A
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419064
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of microRNA-98 inhibits cell proliferation and promotes cell apoptosis via claudin-1 in human colorectal carcinoma.
Zheng YF; Luo J; Gan GL; Li W
J Cell Biochem; 2019 Apr; 120(4):6090-6105. PubMed ID: 30506722
[TBL] [Abstract][Full Text] [Related]
28. Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway.
Gao AM; Ke ZP; Shi F; Sun GC; Chen H
Chem Biol Interact; 2013 Oct; 206(1):100-8. PubMed ID: 23994249
[TBL] [Abstract][Full Text] [Related]
29. Increase in Anticancer Drug-Induced Toxicity by Fisetin in Lung Adenocarcinoma A549 Spheroid Cells Mediated by the Reduction of Claudin-2 Expression.
Eguchi H; Kimura R; Matsunaga H; Matsunaga T; Yoshino Y; Endo S; Ikari A
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886884
[TBL] [Abstract][Full Text] [Related]
30. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
[TBL] [Abstract][Full Text] [Related]
31. Curcumin analog 1, 5-bis (2-trifluoromethylphenyl)-1, 4-pentadien-3-one exhibits enhanced ability on Nrf2 activation and protection against acrolein-induced ARPE-19 cell toxicity.
Li Y; Zou X; Cao K; Xu J; Yue T; Dai F; Zhou B; Lu W; Feng Z; Liu J
Toxicol Appl Pharmacol; 2013 Nov; 272(3):726-35. PubMed ID: 23954767
[TBL] [Abstract][Full Text] [Related]
32. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
[TBL] [Abstract][Full Text] [Related]
33. Acrolein induces heme oxygenase-1 through PKC-delta and PI3K in human bronchial epithelial cells.
Zhang H; Forman HJ
Am J Respir Cell Mol Biol; 2008 Apr; 38(4):483-90. PubMed ID: 18048804
[TBL] [Abstract][Full Text] [Related]
34. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
[TBL] [Abstract][Full Text] [Related]
35. Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways.
Do MT; Kim HG; Khanal T; Choi JH; Kim DH; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2013 Sep; 271(2):229-38. PubMed ID: 23707609
[TBL] [Abstract][Full Text] [Related]
36. P38 and ERK mitogen-activated protein kinases mediate acrolein-induced apoptosis in Chinese hamster ovary cells.
Tanel A; Averill-Bates DA
Cell Signal; 2007 May; 19(5):968-77. PubMed ID: 17196791
[TBL] [Abstract][Full Text] [Related]
37. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
[TBL] [Abstract][Full Text] [Related]
38. Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer.
Primeaux M; Liu X; Gowrikumar S; Fatima I; Fisher KW; Bastola D; Vecchio AJ; Singh AB; Dhawan P
Cancer Lett; 2023 Nov; 579():216479. PubMed ID: 37924938
[TBL] [Abstract][Full Text] [Related]
39. Elevation of sensitivity to anticancer agents of human lung adenocarcinoma A549 cells by knockdown of claudin-2 expression in monolayer and spheroid culture models.
Maruhashi R; Akizuki R; Sato T; Matsunaga T; Endo S; Yamaguchi M; Yamazaki Y; Sakai H; Ikari A
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):470-479. PubMed ID: 29247669
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.
Hu Y; Bally M; Dragowska WH; Mayer L
Mol Cancer Ther; 2003 Jul; 2(7):641-9. PubMed ID: 12883037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]